Predict your next investment

CirculoGene Diagnostics company logo
HEALTHCARE | Disease Diagnosis
circulogene.com

See what CB Insights has to offer

Total Raised

$6.79M

Investors Count

1

CirculoGene Diagnostics Funding, CirculoGene Diagnostics Valuation & CirculoGene Diagnostics Revenue

8 Fundings

CirculoGene Diagnostics's latest funding round was a Loan for $0.68M on April 10, 2020.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

4/10/2020

Loan

$0.68M

$0.00B

((9.99x))

FY 1234

9/9/2019

Debt - IV

$99M

$0.00B

((9.99x))

FY 1234

10

11/16/2018

Unattributed - II

$99M

$0.00B

((9.99x))

FY 1234

10

1/25/2018

Unattributed

$99M

$0.00B

((9.99x))

FY 1234

10

9/21/2017

Debt - III

$99M

$0.00B

((9.99x))

FY 1234

10

Date

4/10/2020

9/9/2019

11/16/2018

1/25/2018

9/21/2017

Round

Loan

Debt - IV

Unattributed - II

Unattributed

Debt - III

Amount

$0.68M

$99M

$99M

$99M

$99M

Investors

Valuation

Revenue

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

Sources

10

10

10

10

CirculoGene Diagnostics Investors

1 Investors

CirculoGene Diagnostics has 1 investors. Paycheck Protection Program invested in CirculoGene Diagnostics's Loan funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

4/10/2020

4/10/2020

1
Loan

Government

DC

First funding

4/10/2020

Last Funding

4/10/2020

Investor

Rounds

1
Loan

Board Seats

Type

Government

Location

DC

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.